- Home
- ATNM vs NHTC Comparison
ATNM vs NHTC Comparison
Compare ATNM & NHTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- NHTC
- Stock Information
- Founded
- ATNM 2000
- NHTC 1988
- Country
- ATNM United States
- NHTC United States
- Employees
- ATNM N/A
- NHTC N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- NHTC Diversified Commercial Services
- Sector
- ATNM Health Care
- NHTC Miscellaneous
- Exchange
- ATNM Nasdaq
- NHTC Nasdaq
- Market Cap
- ATNM 51.5M
- NHTC 55.8M
- IPO Year
- ATNM N/A
- NHTC 1995
- Fundamental
- Price
- ATNM $1.52
- NHTC $4.49
- Analyst Decision
- ATNM Strong Buy
- NHTC
- Analyst Count
- ATNM 3
- NHTC 0
- Target Price
- ATNM $4.67
- NHTC N/A
- AVG Volume (30 Days)
- ATNM 246.6K
- NHTC 18.1K
- Earning Date
- ATNM 08-04-2025
- NHTC 07-30-2025
- Dividend Yield
- ATNM N/A
- NHTC 17.98%
- EPS Growth
- ATNM N/A
- NHTC N/A
- EPS
- ATNM N/A
- NHTC 0.04
- Revenue
- ATNM N/A
- NHTC $42,749,000.00
- Revenue This Year
- ATNM N/A
- NHTC N/A
- Revenue Next Year
- ATNM N/A
- NHTC N/A
- P/E Ratio
- ATNM N/A
- NHTC $111.22
- Revenue Growth
- ATNM N/A
- NHTC N/A
- 52 Week Low
- ATNM $1.03
- NHTC $4.02
- 52 Week High
- ATNM $8.64
- NHTC $7.35
- Technical
- Relative Strength Index (RSI)
- ATNM 42.39
- NHTC 43.00
- Support Level
- ATNM $1.41
- NHTC $4.56
- Resistance Level
- ATNM $1.95
- NHTC $4.77
- Average True Range (ATR)
- ATNM 0.13
- NHTC 0.15
- MACD
- ATNM -0.04
- NHTC -0.01
- Stochastic Oscillator
- ATNM 6.54
- NHTC 7.89
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About NHTC Natural Health Trends Corp.
Natural Health Trends Corp is an international direct-selling and e-commerce company. It offers a line of products such as Wellness, Herbal, Beauty, Lifestyle, and Home. Wellness products include targeted nutrition for joint health, antioxidant support, digestive health, heart health, and vision health. Herbal products include anti-aging and hydrating cleansers, creams, lotions, serums, and toners. Lifestyle products improve the overall quality of life and to support active, physical and healthy lifestyles. Home products are designed to create a clean and natural living environment for the home. It generates a majority of its revenue from Hong Kong and rest from China, Taiwan, Japan, United States and other regions.